Authors:
KYNDT X
PASTURELMICHON U
HACHULLA E
HATRON PY
REMYJARDIN M
Citation: X. Kyndt et al., INTRAVENOUS (IV) CYCLOPHOSPHAMIDE FOR TREATMENT OF SYSTEMIC-SCLEROSISWITH INTERSTITIAL LUNG-DISEASE, Arthritis and rheumatism, 41(9), 1998, pp. 415-415
Authors:
KYNDT X
HEBBAR M
QUEYREL V
HACHULLA E
HATRON PY
DEVULDER B
Citation: X. Kyndt et al., SYSTEMIC-SCLEROSIS AND MALIGNANCY - ASSES SMENT OF RISK-FACTORS ASSOCIATED WITH THE DEVELOPMENT OF CANCER IN 123 PATIENTS WITH SYSTEMIC-SCLEROSIS, La Revue de medecine interne, 18(7), 1997, pp. 528-532
Authors:
LESAVRE P
KYNDT X
VANHILLE P
REUMAUX D
GUILLEVIN L
NOEL LH
Citation: P. Lesavre et al., SERIAL ANCA TESTING HAS LIMITED VALUE DURING THE FOLLOW-UP OF DISEASE-ACTIVITY IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS, Sarcoidosis vasculitis and diffuse lung diseases, 13(3), 1996, pp. 246-248
Authors:
KYNDT X
REUMAUX D
BRIDOUX F
LEMAITRE V
HATRON PY
TRIBOUT B
VANHILLE P
Citation: X. Kyndt et al., PAUCI-IMMUNE GLOMERULONEPHRITIS - RELAPSES AND ASCA MONITORING, Journal of the American Society of Nephrology, 7(9), 1996, pp. 2649-2649